Home » Topics » BioWorld Science

BioWorld Science
RSS

Enyo reports promising phase II data for vonafexor in patients with chronic hepatitis B

Aug. 2, 2021

DNA-dependent protein kinase inhibitors discovered at Chengdu Baiyu Pharmaceutical

Aug. 2, 2021

New glucocorticoid receptor modulators identified at Medshine Discovery

Aug. 2, 2021

FDA clears IND for phase I study of Protollin as treatment of AD

Aug. 2, 2021

Targeting hypoxia-induced metastatic genes shows therapeutic potential in uveal melanoma

Aug. 2, 2021

Discovery of a novel calcitonin gene-related peptide receptor antagonist azepinone series

Aug. 2, 2021

Recombinant HA stably presented on immunogenic liposomes improves immunogenicity in animal models

Aug. 2, 2021

SymBio opens phase IIa study of brincidofovir in subjects with adenovirus infection

July 30, 2021

HA-121-28 studied in phase II for medullary thyroid carcinoma

July 30, 2021

TVB-2640 shows promising efficacy in phase II FASCINATE-1 study in patients with NASH

July 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...